Meta-analysisindependent cross-checkabstract only checked★ key study I-BAR-01 in-depth review
Meta-analysis: weight-loss surgery and survival
Association of metabolic-bariatric surgery with long-term survival in adults with and without diabetes: a one-stage meta-analysis of matched cohort and prospective controlled studies with 174 772 participants.
Overview
Syn NL et al.. Lancet 2021 · PMID 33965067 · DOI 10.1016/S0140-6736(21)00591-2
Across 174,772 people, surgery was linked to about half the risk of death and about 6 more years of median life expectancy; sleeve showed similar effects to bypass.
Does the study support the specific claim? No · Methodological quality: moderate
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Survival
- How was the study done?
Meta-analysis of matched cohorts
- How many people, animals or samples were studied?
174,772
- What was actually found?
Lower mortality
- How large was the observed effect?
HR ~0.51; +6.1 years
- What do the results mean in everyday life?
Surgery is linked to longer, not shorter, life in severe obesity
- What are the study's limitations?
Observational studies
- What does it say about Elawady's specific claim?
Contradicts 'lethal'
- Do the results apply to Germany and Europe?
Includes Europe
- What can explicitly not be concluded from this study?
Exact causal size
Scientific in-depth review
1. Full reference
- Authors
- Syn NL et al.
- Journal
- Lancet
- Year
- 2021
- Identifier
- PMID 33965067 DOI 10.1016/S0140-6736(21)00591-2
- Verification
- verified – PubMed efetch 2026-10-25
- Retracted
- no
- Corrections
- none
- Extent checked
- abstract only
- Conflicts of interest and funding
Several authors declare consultancies/funding from companies (Bariatric Advantage, Novo Nordisk, Ethicon, Johnson & Johnson etc.); study funding: none.
2. Research question
Long-term survival after metabolic-bariatric surgery vs usual care
3. Study design and population
- Study design
- Meta-analysis – One-stage individual-level (reconstructed) meta-analysis of 16 matched cohorts and 1 prospective controlled trial
- Population
Adults with severe obesity
- Country
Multinational
- Period
Literature to Feb 2021
- Sample size
174,772 participants; 7712 deaths
4. Methods and endpoints
- Exposure / intervention
Metabolic-bariatric surgery
- Comparator
Usual care
- Endpoints
All-cause mortality, life expectancy
- Statistical methods
Shared-frailty Cox; Gompertz extrapolation
5. Actual results
- Results
Hazard of death reduced by 49.2% (95% CI 46.3-51.9); median life expectancy +6.1 years (5.2-6.9). With diabetes HR 0.409 (+9.3 years); without diabetes HR 0.704 (+5.1 years). NNT over 10 years 8.4 (diabetes) and 29.8 (no diabetes). No difference between bypass, banding and sleeve (I2 3.4%).
- Absolute risks
NNT 8.4 (diabetes) and 29.8 (no diabetes) over 10 years
- Authors' conclusion
Surgery associated with substantially lower mortality and longer life expectancy; greater benefit with diabetes.
6. Strengths
- Very large
- Prespecified, PROSPERO registered
- Includes sleeve
7. Weaknesses
- Observational primary studies (confounding, healthy-patient selection)
- Reconstructed IPD
8. Risk of bias
- Orienting tool
- AMSTAR 2
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- some concerns
- Rationale
Includes SOS and other cohorts; not independent of A-BAR-02/05. Several authors report industry consultancies (COI statement).
9. Assessment of the statistical interpretation
Large relative effect; residual confounding could inflate estimate.
10. Relevance to the specific claim
Contradicts the claim that sleeve/bariatric surgery is lethal or shortens life.
11. Independent contrary findings
All primary studies observational.
12. Transferability to Germany and Europe
Includes European cohorts.
13. Overall methodological judgement
Best available summary on survival; moderate certainty because non-randomized.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | moderate |
| Risk of bias | some concerns |
| Precision of results | high |
| Directness | direct |
| Reproducibility | replicated |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
Randomized survival data lacking.
15. Linked fact checks
- Sleeve gastrectomy (and bariatric surgery in general) is a lethal operation that kills patients / shortens life. – Studies contradicting or limiting the claim
- Even the largest long-term study (SOS) showed that surgery patients still die 5.5 years earlier than the general population. – Studies contradicting or limiting the claim
- Sleeve gastrectomy is a physiologically wrong operation and a 'transgression against God's creation', because the stomach is not a bag but an endocrine, muscular and immune organ whose functions are lost. – Studies contradicting or limiting the claim